Concepedia

Patrick Chun

PC

11

Publications

559

Citations

11

H-Index

2006

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Michigan

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of California, Los Angeles

Moffitt Cancer Center

Patrick Chun is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, radiation oncology, and oncology.

Top concepts

Publications per year

2006–2019

11

Publications

11

Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors

Stergios J. Moschos, Ryan J. Sullivan, Wen-Jen Hwu et al. · JCI Insight · 2018 · 145 citations · Full text

Synergistic Effects of Gemcitabine and Gefitinib in the Treatment of Head and Neck Carcinoma

Patrick Chun, Felix Y. Feng, Ashley M. Scheurer et al. · Cancer Research · 2006 · 78 citations · Full text

, , +19

Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity

Felix Y. Feng, Sooryanarayana Varambally, Scott A. Tomlins et al. · Oncogene · 2006 · 71 citations · Full text

, , +8

Phase 1 First-in-Human Trial of AMV564, a Bivalent Bispecific (2:2) CD33/CD3 T-Cell Engager, in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)

Peter Westervelt, Jörge E. Cortes, Jessica K. Altman et al. · Blood · 2019 · 68 citations

Effect of Epidermal Growth Factor Receptor Inhibitor Class in the Treatment of Head and Neck Cancer with Concurrent Radiochemotherapy <i>In vivo</i>

Felix Y. Feng, Carlos López, Daniel P. Normolle et al. · Clinical Cancer Research · 2007 · 47 citations

Rows per page

1–5 of 11